ACHC:NGS-Acadia Healthcare Company Inc. (USD)

EQUITY | Medical Care Facilities | Nasdaq Global Select

Last Closing

USD 73.59

Change

0.00 (0.00)%

Market Cap

USD 3.35B

Volume

0.69M

Analyst Target

USD 34.46
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Acadia Healthcare Co Inc develops and operates inpatient psychiatric facilities, group homes, substance abuse facilities and facilities providing outpatient behavioral healthcare services to serve the behavioral health and recovery needs of communities.

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-04-28 )

Largest Industry Peers for Medical Care Facilities

Symbol Name Price(Change) Market Cap
ENSG The Ensign Group Inc

-0.90 (-0.57%)

USD 8.50B
OPCH Option Care Health Inc

-6.95 (-22.79%)

USD 5.14B
SGRY Surgery Partners Inc

-0.65 (-2.16%)

USD 4.02B
AMED Amedisys Inc

-0.08 (-0.08%)

USD 3.12B
LFST Lifestance Health Group Inc

-0.01 (-0.15%)

USD 2.67B
ASTH Astrana Health Inc

-0.23 (-0.41%)

USD 2.55B
ADUS Addus HomeCare Corporation

-4.09 (-3.15%)

USD 2.35B
AVAH Aveanna Healthcare Holdings In..

+0.01 (+0.20%)

USD 0.96B
HCSG Healthcare Services Group Inc

+0.03 (+0.27%)

USD 0.76B
CMPS Compass Pathways Plc

-0.03 (-0.48%)

USD 0.44B

ETFs Containing ACHC

CHEP 0.00 % 1.12 %

N/A

N/A
YLD Principal Active High Yie.. 0.00 % 0.65 %

+0.02 (+0.10%)

USD 0.24B

Market Performance

  Market Performance vs. Industry/Classification (Medical Care Facilities) Market Performance vs. Exchange (Nasdaq Global Select)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -5.36% 60% D- 43% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -5.36% 60% D- 43% F
Trailing 12 Months  
Capital Gain 1.80% 68% D+ 54% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 1.80% 68% D+ 51% F
Trailing 5 Years  
Capital Gain 129.83% 91% A- 88% B+
Dividend Return N/A N/A N/A N/A N/A
Total Return 129.83% 91% A- 87% B+
Average Annual (5 Year Horizon)  
Capital Gain 34.84% 79% B- 87% B+
Dividend Return 34.84% 79% B- 87% B+
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 56.13% 43% F 29% F
Risk Adjusted Return 62.08% 93% A 87% B+
Market Capitalization 3.35B 100% F 91% A-

Key Financial Ratios

  Ratio vs. Industry/Classification (Medical Care Facilities) Ratio vs. Market (Nasdaq Global Select)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
Market Value  
Price / Earning Ratio 430.10 70% 37%
Price/Book Ratio 2.43 46% 40%
Price / Cash Flow Ratio 14.71 35% 18%
Price/Free Cash Flow Ratio 43.16 7% 5%
Management Effectiveness  
Return on Equity -0.54% 68% 58%
Return on Invested Capital 12.36% 87% 82%
Return on Assets 6.12% 83% 88%
Debt to Equity Ratio 48.26% 37% 42%

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

Superior return on assets

The company management has delivered better return on assets in the most recent 4 quarters than its peers, placing it in the top quartile.

Superior capital utilization

The company management has delivered better return on invested capital in the most recent 4 quarters than its peers, placing it in the top quartile.

High market capitalization

This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.

Positive cash flow

The company had positive total cash flow in the most recent four quarters.

Positive free cash flow

The company had positive total free cash flow in the most recent four quarters.

What to not like:
Highly leveraged

The company is in the bottom half compared to its sector peers on debt to equity and is highly leveraged. However, do check the news and look at its sector and management statements. Sometimes this is high because the company is trying to grow aggressively.

Overpriced on cashflow basis

The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Overpriced compared to book value

The stock is trading high compared to its peers median on a price to book value basis.

High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.

Overpriced on free cash flow basis

The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Low Revenue Growth

This stock has shown below median revenue growth in the previous 5 years compared to its sector